Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 1 Results

  1. 1
    083307

    Evaluation and policy change in UNICEF: the case of GMP.

    Pearson R

    In: Growth Promotion for Child Development. Proceedings of a colloquium held in Nyeri, Kenya, 12-13 May 1992, edited by J. Cervinskas, N.M. Gerein, and Sabu George. Ottawa, Canada, International Development Research Centre [IDRC], 1993 Feb. 33-42.

    UNICEF has been a vocal advocate of the widespread application of growth monitoring and promotion (GMP) for 10 years. The UNICEF Evaluation Office is an office within UNICEF responsible for conducting global thematic evaluations of a wide range of UNICEF activities. Evaluations involve reviewing literature, drafting terms of reference for evaluating activities in selected countries, and reviewing findings leading to policy changes for UNICEF at the global level. This paper describes progress made in conducting evaluations of GMP efforts coordinated together with UNICEF's Senior Nutrition Advisor. Data were collected for 1990-91 through focus groups and interviews in China, Ecuador, Indonesia, Malawi, Thailand, Zaire, Zambia and subsequently analyzed. A summary is presented of actions reported to have been stimulated by the assessment and analysis of anthropometric data at household and community levels and constraints to actions identified. The following lessons learned were agreed upon during a review meeting: resources are short for GMP; programs should be implemented only where there is demand; GMP should no longer be promoted as an entry point to improve the health system or other sectors; existing, poorly done GMP programs waste resources and incur large opportunity costs; promoting growth for child development is important especially where growth faltering is prevalent; program management may take several forms; inabilities to analyze and respond are primary constraints to good GMP in most country programs; GMP can promote empowerment where the context allows; and GM data should not be analyzed under the auspices of the health sector in order to avoid bias.
    Add to my documents.